Roivant Sciences Ltd. Warrant
ROIVW
ROIVW was delisted on the 1st of September, 2023.
36 hedge funds and large institutions have $25.5M invested in Roivant Sciences Ltd. Warrant in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 7 closing their positions.
10% less funds holding
Funds holding: 40 → 36 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
65% less capital invested
Capital invested by funds: $71.8M → $25.5M (-$46.3M)
69% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 13
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Centiva Capital
New York
|
+$917K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$125K |
| 3 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$76K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$65.8K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$41.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIG
American International Group
New York
|
-$18.3M |
| 2 |
TCA
Taconic Capital Advisors
New York
|
-$258K |
| 3 |
SC
Sculptor Capital
New York
|
-$256K |
| 4 |
DCP
Diameter Capital Partners
New York
|
-$205K |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$135K |
ROIVW Hedge Fund Activity: Q1 2022 in Review
36 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q1 2022, worth a combined $25.5M — down 65% from $71.8M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ROIVW and 3 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 4 added.
The largest buyer was Centiva Capital, adding an estimated $917K. The largest seller was American International Group, exiting entirely with an estimated $18.3M sold.
- 36 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q1 2022, down from 40 in Q4 2021.
- Funds reported $25.5M of Roivant Sciences Ltd. Warrant stock for Q1 2022, down 65% quarter-over-quarter.
- 3 funds opened new Roivant Sciences Ltd. Warrant positions in Q1 2022 and 7 closed out, a net change of -4 holders.
- The largest Roivant Sciences Ltd. Warrant buyer in Q1 2022 was Centiva Capital, an estimated $917K added.
- The largest Roivant Sciences Ltd. Warrant seller in Q1 2022 was American International Group, an estimated $18.3M sold.
Based on aggregated 13F filings for Q1 2022.